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Purpose: The aim of this study was to describe intraoperative optical coherence tomography 
(OCT) as an adjunctive device for peripheral synechiolysis in a post-penetrating keratoplasty 
patient.
Case report: A 75-year-old female patient presented for follow-up 9 months after a penetrating 
keratoplasty in the left eye. She presented with anterior peripheral synechiae involving the 
graft for three clock hours. Peripheral native cornea appeared totally opaque. Synechiolysis 
was planned, and intraoperative OCT allowed us to detect nonclinically visible synechiae and 
to confirm complete synechiolysis immediately after surgery. No postoperative complication 
was recorded. Two months after surgery, the graft was clear and anterior segment OCT did not 
reveal any residual synechiae or recurrence.
Conclusion: Intraoperative OCT is useful to overcome the difficulties in visualization through 
clinically opaque corneas, as it gives real-time feedback upon the anatomy, the extension of the 
remaining lesions, and the success of the surgery.
Keywords: penetrating keratoplasty, peripheral anterior synechiae, intraoperative optical 
coherence tomography
Introduction
Optical coherence tomography (OCT) is a high-resolution imaging modality used to 
image the anterior segment, first described in 1994.1 High-speed OCT provides in 
vivo cross-sectional images of the anterior eye, similar to histological sections, and 
could be a potential tool for noninvasive evaluation of the anterior chamber angle,2 
especially in cases of corneal opacity.
Intraoperative real-time microscope-integrated OCT (iOCT) is an emerging 
modality with the potential to revolutionize the surgical techniques by providing a 
real-time dynamic feedback of the tissue alterations during surgery.3,4 In 2014, the 
PIONEER study described the feasibility, utility, and safety of iOCT in ophthalmic 
surgery and showed that the tool impacted surgical decision in .40% of the cases.3 
iOCT has already been described in DMEK and DSAEK surgeries with advanced 
bullous keratopathy.5–7
Anterior synechiae after penetrating keratoplasty (PK) is a major risk factor for 
developing glaucoma and endothelial failure by rejection.8,9 Glaucoma, in turn, is a 
Correspondence: Georgios Kymionis
Department of ophthalmology, 
University of Lausanne, Jules-Gonin 
eye Hospital, 15 avenue de France, 
1004 Lausanne, switzerland
Tel +41 21 626 8585
email gkymionis@gmail.com 
Journal name: Therapeutics and Clinical Risk Management
Article Designation: Case report
Year: 2018
Volume: 14
Running head verso: Petrovic et al
Running head recto: iOCT-guided synechiolysis in post-PK patient
DOI: 167025





major risk factor for graft failure, and furthermore, glaucoma 
surgery is associated with shorter time to graft rejection.9
Although management of peripheral anterior synechiae 
(PAS) after PK is not clearly defined in the literature, clini-
cians often tend to surgically treat this condition, in order to 
avoid complications such as glaucoma and graft rejection.
We describe here the first case of iOCT-guided syn-
echiolysis in a patient with peripheral corneal opacity after 
a PK.
Case report
A 75-year-old female patient presented for follow-up 
9 months after a PK in the left eye.
She had undergone a deep sclerectomy for open-angle 
glaucoma 12 years prior to the keratoplasty followed by cata-
ract surgery 3 years later and a Baerveldt tube implantation, 
due to medically uncontrolled intraocular pressure, 5 years 
later. Implantation of the Baerveldt tube was performed in the 
sulcus to avoid any corneal touch. She had also been treated 
for recurrent anterior uveitis. Uveitic workup was negative 
for sarcoidosis, syphilis, lyme, and tuberculosis. As herpetic 
origin could not be excluded, patient was treated with pro-
phylactic systemic valaciclovir to avoid recurrence.
One year after the last surgery, patient presented with 
endothelial decompensation and stromal edema. A DMEK 
was performed under local anesthesia, without any intra-
operative complication. Postoperative treatment consisted 
of dexamethasone and ofloxacin drops four times a day. 
Valaciclovir was continued. One month after surgery, the 
patient presented with total corneal opacification, stromal 
edema, and graft failure. After 2 months, she developed 
anterior stromal fibrosis. A PK was planned. A 7.75 mm graft 
was sutured after a 7.5 mm trephination. The postoperative 
treatment included dexamethasone and tobramycine drops 
(Tobradex®; Alcon, Fort Worth, TX, USA) six times a day. 
Valaciclovir was continued. No postoperative complication 
was recorded for the first 9 months.
Nine months after the surgery, the patient presented 
with anterior peripheral synechiae involving the graft for 
three clock hours. Peripheral native cornea appeared totally 
opaque (Figure 1). Graft was clear with no sign of rejection. 
Anterior chamber was calm, with no sign of recurrent uveitis. 
Intraocular pressure was 15 mmHg.
Because of the history of uveitis, synechiolysis was 
planned. Surgery was performed under local anesthesia 
and was assisted by Leica enfocus Ultra deep OCT (Leica 
Microsystems, Wetzlar, Germany), which delivers high defini-
tion real-time images of the anterior segment. Due to peripheral 
corneal opacification, anterior synechiae could not be properly 
seen with slit lamp microscopy or operative microscope. 
Intraoperative OCT allowed us to detect nonclinically visible 
synechiae and to confirm complete synechiolysis immediately 
after surgery (Figure 2). Synechiolysis was performed using 
a viscoelastic cannula (Viscoat®, Alcon, Fort Worth, USA) 
and an ophthalmic dispersive device (Viscoat).
No postoperative complication was recorded. Postop-
erative treatment included tobramycine and dexamethasone 
drops six times a day for 3 months with progressive tapering. 
Valaciclovir was continued 1 g three times a day for 1 month 
and then tapered weekly until 500 mg per day. Two months 
after the surgery, vision was 0.2 limited by advanced glau-
comatous neuropathy. The graft was clear and anterior seg-
ment OCT (Spectralis, Heidelberg, Germany) did not reveal 
any residual synechiae or recurrence.
ethics
Written informed consent has been provided by the patient 
for the publication of her case details and images.
Discussion
We describe a case of synechiolysis intraoperatively guided 
by OCT. The device allowed good quality images of the 
anterior segment, even in the presence of corneal opacifica-
tion, as infrared illumination used by the device scatters 
less than light used by microscopes.7 iOCT helped localize 
the synechiae, facilitated the synechiolysis, and confirmed 
Figure 1 Color photography showing penetrating keratoplasty with peripheral 
opacification.
Note: There is a clinically visible anterior synechiae from 3 to 6 o’clock.




ioCT-guided synechiolysis in post-pK patient
complete synechiolysis at the end of the procedure. Without 
the device, operative strategy would be planned differently. 
Anterior segment OCT would be performed preoperatively, 
and synechiae position would be marked.
iOCT has already been described in anterior segment 
surgery, especially for lamellar keratoplasty such as DMEK 
and DSAEK.3,5–7 In DMEK, iOCT has been reported to help 
in graft rotation without touching the graft as well as graft 
orientation.5,6 In DSAEK surgery, iOCT has been reported 
to help in graft–host interactions and to verify the presence 
or absence of fluid interface.7 For both surgeries, iOCT may 
expand their indications and diminish the need for PK, which 
is a more invasive surgery with a higher comorbidity rate. 
The actual impact on overall surgical time has been studied 
and appears to be generally minimal.3
However, this device has still some limitations: distortion 
of the images during eye movements and restriction of the 
scanning zone necessitate frequent adjustment of the view-
ing field during surgery. Automated tracking would be a 
welcome addition to facilitate rapid imaging of the region of 
interest and to minimize surgeon burden of manual adjust-
ment.10 Moreover, metallic instruments create difficulties for 
intraoperative OCT systems due to the light scattering and 
shadowing characteristics of metal, which render underlying 
tissue invisible.10
Conclusion
Despite these limitations, it seems that iOCT is a valuable 
device in order to overcome the difficulties in visualization 
through clinically opaque corneas.
To the best of our knowledge, this is the first report of 
intraoperative OCT-guided anterior synechiolysis.
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Figure 2 Intraoperative oCT showing (A) peripheral anterior synechiae posterior to the opacification and (B) after surgery, deepening of the anterior chamber and lysis 
of adhesion.
Abbreviation: oCT, optical coherence tomography.
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